Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China. It operates through four segments: Cell Therapies; Developing New Anti-Cancer Drugs; E-commerce Platform for Pharmaceutical and Healthcare Products; and Dete...
Beroni Group reported revenue of 468,730 AUD for fiscal year 2023, down 26.6% from fiscal year 2022, and net income of -9.23 million AUD. Its market capitalization was $217,518 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 9, 2026.
No profile data available.